Literature DB >> 8561095

Gender differences in high-risk sex behaviours among heterosexual drug injectors and crack smokers.

R E Booth1.   

Abstract

This study was designed to assess gender differences in high-risk sex behaviors related to the transmission of HIV among injection drug users (IDUs) and crack smokers. Using a standard national survey instrument, 593 verified drug users were questioned about their sexual activities and drug use in the 30 day period prior to the interview. High-risk sex behaviors included nonuse of condoms, exchanging sex for drugs or money, sex with an IDU, and sex with more than one partner. Results showed that IDUs who engaged in needle risk practices were more likely report nonuse of condoms than IDUs who practiced safer needle use. African-American ethnicity was a more powerful determinant of exchanging sex than smoking crack cocaine. Sex with more than one partner in the previous 30 day was reported by 11% of married males and 15% of married females. Independently, marital status was found to be a marker for high-risk sex behaviors, in particular, sex with an IDU and nonuse of condoms, behaviors reported more often by married than unmarried respondents. Needle risk, more common among females than males, was associated with sex with an IDU. Approximately one-fourth of the injectors reporting sex with only non-IDUs also reported needle risk, sex with more than one partner, and nonuse of condoms. These findings show the dual threat drug injectors face for HIV infection, through sex and needle risk behaviors, and the pivotal role IDUs play in the heterosexual transmission of HIV to noninjectors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561095     DOI: 10.3109/00952999509002708

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  16 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  Gender differences in the rates and correlates of HIV risk behaviors among drug abusers.

Authors:  Audrey Brooks; Christina S Meade; Jennifer Sharpe Potter; Yuliya Lokhnygina; Donald A Calsyn; Shelly F Greenfield
Journal:  Subst Use Misuse       Date:  2010-06-10       Impact factor: 2.164

Review 3.  The dynamics of substance use and sex networks in HIV transmission.

Authors:  Maureen Miller
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

4.  Predictors of methamphetamine injection in out-of-treatment IDUs.

Authors:  Karen F Corsi; Carol F Kwiatkowski; Robert E Booth
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

Review 5.  Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV.

Authors:  J S Gearon; A S Bellack
Journal:  Community Ment Health J       Date:  1999-10

6.  Gender differences between predictors of HIV status among PWID in Ukraine.

Authors:  K F Corsi; S Dvoryak; C Garver-Apgar; J M Davis; J T Brewster; O Lisovska; R E Booth
Journal:  Drug Alcohol Depend       Date:  2014-02-20       Impact factor: 4.492

7.  Retrospective accounts of injection initiation in intimate partnerships.

Authors:  Janie Simmons; Sonali Rajan; James M McMahon
Journal:  Int J Drug Policy       Date:  2012-03-06

8.  Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior?

Authors:  C M Lollis; H S Strothers; D D Chitwood; M McGhee
Journal:  J Behav Med       Date:  2000-12

9.  Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

10.  Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors.

Authors:  Kara S Riehman; Alex H Kral; Rachel Anderson; Neil Flynn; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.